Vedanta Biosciences
Latest round
- Series D
Last raised
- Jul 2021
Total raised
- $122M
Investors
- 21
About Vedanta Biosciences
Vedanta Biosciences, Inc.Founded in 2010 and headquartered in Cambridge, US, Vedanta Biosciences, Inc. specializes in biotherapeutic solutions for gastrointestinal issues.Vedanta Biosciences, Inc. specializes in the development of first-in-class Live Biotherapeutic Products (LBPs) designed to address serious gastrointestinal diseases through the utilization of defined consortia of bacteria. These innovative products aim to restore gut microbiota balance, targeting conditions such as inflammatory bowel disease (IBD) and recurrent Clostridium difficile infections. By leveraging the ability of these biotherapeutic agents to stimulate immune responses, Vedanta seeks to provide effective treatment options for patients suffering from gut dysbiosis, a noted contributor to various gastrointestinal ailments. The company is conducting clinical trials to evaluate the efficacy and safety of its leading candidates, including VE202 and VE303.The revenue model for Vedanta Biosciences operates primarily through partnerships and collaborations with healthcare institutions and pharmaceutical companies, focusing on clinical trial agreements and product development initiatives. The company engages in B2B transactions with healthcare providers and research institutions that seek innovative treatment options for gastrointestinal diseases. Specific pricing structures for its products are not disclosed, but revenue is generated from milestone payments, royalties, and potential product sales once the drugs receive regulatory approval. Vedanta's flagship products, including VE202 and VE303, are central to its revenue strategy as the company prepares to bring these therapeutics to market, aligning with its mission to improve patient outcomes in gastrointestinal health. In August 2026, Vedanta Biosciences, Inc.
Who invested in Vedanta Biosciences
21 investors across 4 rounds
See all investors in Vedanta Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vedanta Biosciences
Who invested in Vedanta Biosciences?
Vedanta Biosciences has 21 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vedanta Biosciences raised?
Vedanta Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vedanta Biosciences last raise money?
Vedanta Biosciences's most recent round on record is a Series D, in Jul 2021.
What does Vedanta Biosciences do?
Vedanta Biosciences is a biotechnology company.
Where is Vedanta Biosciences headquartered?
Vedanta Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Vedanta Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vedanta Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Vedanta Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.